Prevalence and Predictors of Anemia Among Adults on Highly Active Antiretroviral Therapy in Northeast Ethiopia: A Retrospective Cohort Study

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2022 Mar 25

PMID 35333889

Authors

Teklehaimanot Fentie Wendie

Getnet Mengistu

Affiliations

Soon will be listed here.

Abstract

Background: Although antiretroviral therapy has significantly altered the natural history of human immunodeficiency virus infection and improved the quality of life of patients, there are conflicting reports regarding its impact on hematological outcomes. Thus, this study aimed at investigating the prevalence and predictors of anemia among adults on antiretroviral therapy in Northeast Ethiopia.

Materials And Methods: A retrospective cohort study was carried out among adults who began antiretroviral treatment between September 2005 and January 2019 at two governmental hospitals in Dessie town. Data were collected from patients' medical records using a pretested data extraction instrument. Anemia was the primary outcome variable of the study. It was defined based on WHO criteria after adjustment for altitude and smoking status of measured values. Data were entered and validated using EpiData Version 3.1 and then exported to SPSS Version 20.0 for analysis. Descriptive analysis was done for prevalence and binary logistic regression was carried out to assess whether covariates were associated with experiencing anemia. Statistical significance has been considered at p-value <0.05.

Results: Medical records of 392 patients (mean age: 35.58 ± 9.46 years) were reviewed. Of the total 392 patients, 218 (55.6%) were females, 261 (66.6%) were categorized under WHO clinical stage III/IV and 134 (34.2%) had a baseline CD4 cell count of <100 cells/mm3. The mean baseline CD4 cell count was 179 cells/mm3 (range: 2 to 853 cells) and 230 (58.7%) of the participants were on zidovudine-based regimen. Anemia was diagnosed among 162 (41.3%) patients. After adjustment for other confounding factors, risk of anemia was significantly associated with low baseline CD4 cell count (AOR 1.80, 95% CI 1.05-3.06) and tenofovir based regimen (AOR 2.05, 95% CI 1.31-3.21). On the other hand, being educated was found to be protective (AOR 0.40, 95% CI 0.21-0.78).

Conclusion: In this research, the prevalence of anemia was relatively high. Low baseline CD4 cell count and tenofovir based regimen were independent predictors of anemia; while being educated was protective. Treatment programs should focus on early diagnosis and treatment of HIV as well as routine screening and proper treatment of anemia.

Citing Articles

Unveiling the prevalence of anaemia and its predictors among adults on highly active antiretroviral therapy in the dolutegravir era: a retrospective cross-sectional study.

Sisay Zewdu W, Molla Zeleke M, Ferede Y, Kassie A, Singh P, Alemu M BMJ Open. 2024; 14(9):e086480.

PMID: 39242159 PMC: 11590816. DOI: 10.1136/bmjopen-2024-086480.

Prevalence, severity and associated risk factors of anemia among human immunodeficiency virus-infected adults in Sawla General Hospital, Southern Ethiopia: A facility-based cross-sectional study.

Hadgu R, Husen A, Milkiyas E, Alemayoh N, Zemoy R, Tesfaye A PLoS One. 2023; 18(12):e0284505.

PMID: 38085717 PMC: 10715647. DOI: 10.1371/journal.pone.0284505.

Determinates of anemia among Human Immune Deficiency Virus positive children on Anti-retro Viral Therapy in selected health facilities, Northwest Ethiopia: A Case-Control Study.

Tiruneh M, Bizuneh F J Nutr Sci. 2023; 12:e95.

PMID: 37706072 PMC: 10495818. DOI: 10.1017/jns.2023.79.

References

Johannessen A, Naman E, Gundersen S, Bruun J . Antiretroviral treatment reverses HIV-associated anemia in rural Tanzania. BMC Infect Dis. 2011; 11:190. PMC: 3145581. DOI: 10.1186/1471-2334-11-190. View

Obirikorang C, Yeboah F . Blood haemoglobin measurement as a predictive indicator for the progression of HIV/AIDS in resource-limited setting. J Biomed Sci. 2009; 16:102. PMC: 2783029. DOI: 10.1186/1423-0127-16-102. View

Ageru T, Koyra M, Gidebo K, Abiso T . Anemia and its associated factors among adult people living with human immunodeficiency virus at Wolaita Sodo University teaching referral hospital. PLoS One. 2019; 14(10):e0221853. PMC: 6785157. DOI: 10.1371/journal.pone.0221853. View

Volberding P, Levine A, Dieterich D, Mildvan D, Mitsuyasu R, Saag M . Anemia in HIV infection: clinical impact and evidence-based management strategies. Clin Infect Dis. 2004; 38(10):1454-63. DOI: 10.1086/383031. View

Negesse A, Getaneh T, Temesgen H, Taddege T, Jara D, Abebaw Z . Prevalence of anemia and its associated factors in human immuno deficiency virus infected adult individuals in Ethiopia. A systematic review and meta-analysis. BMC Hematol. 2018; 18:32. PMC: 6233542. DOI: 10.1186/s12878-018-0127-y. View

Gedefaw L, Yemane T, Sahlemariam Z, Yilma D . Anemia and risk factors in HAART naïve and HAART experienced HIV positive persons in south west Ethiopia: a comparative study. PLoS One. 2013; 8(8):e72202. PMC: 3745448. DOI: 10.1371/journal.pone.0072202. View

Jin Y, Li Q, Meng X, Xu Q, Yuan J, Li Z . Prevalence of anaemia among HIV patients in rural China during the HAART era. Int J STD AIDS. 2015; 28(1):63-68. DOI: 10.1177/0956462415622866. View

Woldeamanuel G, Wondimu D . Prevalence of anemia before and after initiation of antiretroviral therapy among HIV infected patients at Black Lion Specialized Hospital, Addis Ababa, Ethiopia: a cross sectional study. BMC Hematol. 2018; 18:7. PMC: 5856395. DOI: 10.1186/s12878-018-0099-y. View

Harris R, Sterne J, Abgrall S, Dabis F, Reiss P, Saag M . Prognostic importance of anaemia in HIV type-1-infected patients starting antiretroviral therapy: collaborative analysis of prospective cohort studies. Antivir Ther. 2009; 13(8):959-67. PMC: 4507810. View

10.

Odunukwe N, Idigbe O, Kanki P, Adewole T, Onwujekwe D, Audu R . Haematological and biochemical response to treatment of HIV-1 infection with a combination of nevirapine + stavudine + lamivudine in Lagos Nigeria. Turk J Haematol. 2016; 22(3):125-31. View

11.

Katemba C, Muzoora C, Muwanguzi E, Mwambi B, Atuhairwe C, Taremwa I . Hematological abnormalities in HIV-antiretroviral therapy naïve clients as seen at an immune suppression syndrome clinic at Mbarara Regional Referral Hospital, southwestern Uganda. J Blood Med. 2018; 9:105-110. PMC: 6027711. DOI: 10.2147/JBM.S157148. View

12.

Volberding P . The impact of anemia on quality of life in human immunodeficiency virus-infected patients. J Infect Dis. 2002; 185 Suppl 2:S110-4. DOI: 10.1086/340198. View

13.

Yesuf T, Muhie O, Shibru H . Prevalence and predictors of anemia among adult HIV infected patients at the University of Gondar Hospital, Northwest Ethiopia. HIV AIDS (Auckl). 2019; 11:211-217. PMC: 6736206. DOI: 10.2147/HIV.S209446. View

14.

Moore R . Anemia and human immunodeficiency virus disease in the era of highly active antiretroviral therapy. Semin Hematol. 2000; 37(4 Suppl 6):18-23. DOI: 10.1016/s0037-1963(00)90064-7. View

15.

Moore R, Keruly J, Link G, Wang M, Richman D, Chaisson R . Long-term safety and efficacy of zidovudine in patients with advanced human immunodeficiency virus disease. Zidovudine Epidemiology Study Group. Arch Intern Med. 1991; 151(5):981-6. View

16.

Sah S, Dahal P, Tamang G, Mandal D, Shah R, Pun S . Prevalence and Predictors of Anemia in HIV-Infected Persons in Nepal. HIV AIDS (Auckl). 2020; 12:193-200. PMC: 7276376. DOI: 10.2147/HIV.S244618. View

17.

Moyle G . Anaemia in persons with HIV infection: prognostic marker and contributor to morbidity. AIDS Rev. 2002; 4(1):13-20. View

18.

Assefa M, Abegaz W, Shewamare A, Medhin G, Belay M . Prevalence and correlates of anemia among HIV infected patients on highly active anti-retroviral therapy at Zewditu Memorial Hospital, Ethiopia. BMC Hematol. 2015; 15:6. PMC: 4455710. DOI: 10.1186/s12878-015-0024-6. View

19.

Moh R, Danel C, Sorho S, Sauvageot D, Anzian A, Minga A . Haematological changes in adults receiving a zidovudine-containing HAART regimen in combination with cotrimoxazole in Côte d'Ivoire. Antivir Ther. 2005; 10(5):615-24. DOI: 10.1177/135965350501000510. View

20.

Akilimali P, Mutombo P, Kayembe P, Kaba D, Mapatano M . [Determinants of survival in HIV patients receiving antiretroviral therapy in Goma, Democratic Republic of Congo]. Rev Epidemiol Sante Publique. 2014; 62(3):201-6. DOI: 10.1016/j.respe.2014.03.004. View